Literature DB >> 2569037

P300 abnormality in schizophrenic subtypes.

D St Clair1, D Blackwood, W Muir.   

Abstract

P300 and other long latency event-related potentials were recorded in 65 schizophrenic subjects and results were compared to findings in 119 healthy controls. Highly significant differences in P300 latency and amplitude were found between the two groups. Forty six per cent of schizophrenics had P300 latency more than two standard deviations longer than the mean for controls, 35% had a P300 amplitude smaller than the mean for controls by the same amount, and 24% were more than two standard deviations outside the mean for controls on both measures. These differences were independent of chronicity of illness, clinical subtype, family psychiatric history or the effects of neuroleptic medication. They confirm that P300 abnormality is present as a stable trait in a high proportion of schizophrenics. The status of abnormal P300 as a biological vulnerability factor for major mental illness is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569037     DOI: 10.1016/0022-3956(89)90016-2

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

1.  Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia.

Authors:  Holly K Hamilton; Veronica B Perez; Judith M Ford; Brian J Roach; Judith Jaeger; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

Review 2.  Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.

Authors:  Bruce I Turetsky; Monica E Calkins; Gregory A Light; Ann Olincy; Allen D Radant; Neal R Swerdlow
Journal:  Schizophr Bull       Date:  2006-11-29       Impact factor: 9.306

3.  Diagnostic specificity of neurophysiological endophenotypes in schizophrenia and bipolar disorder.

Authors:  Jason K Johannesen; Brian F O'Donnell; Anantha Shekhar; John H McGrew; William P Hetrick
Journal:  Schizophr Bull       Date:  2012-08-27       Impact factor: 9.306

4.  Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.

Authors:  Deepak Cyril D'Souza; Daniel J Fridberg; Patrick D Skosnik; Ashley Williams; Brian Roach; Nagendra Singh; Michelle Carbuto; Jacqueline Elander; Ashley Schnakenberg; Brian Pittman; R Andrew Sewell; Mohini Ranganathan; Daniel Mathalon
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

5.  Toward a modern search for schizophrenia genes.

Authors:  M Leboyer
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

Review 6.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun

7.  Late auditory event-related evoked potential (P300) in Down's syndrome patients.

Authors:  Carla Patrícia Hernandez Alves Ribeiro César; Heloisa Helena Caovilla; Mário Sérgio Lei Munhoz; Maurício Malavasi Ganança
Journal:  Braz J Otorhinolaryngol       Date:  2010 Mar-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.